Literature DB >> 32442066

De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

E Shelley Hwang1, Lawrence Solin2,3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32442066      PMCID： PMC7343434          DOI： 10.1200/JCO.19.02888

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  67 in total

1.  Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

Authors:  Carl-Magnus Rudenstam; David Zahrieh; John F Forbes; Diana Crivellari; Stig B Holmberg; Piercarlo Rey; David Dent; Ian Campbell; Jürg Bernhard; Karen N Price; Monica Castiglione-Gertsch; Aron Goldhirsch; Richard D Gelber; Alan S Coates
Journal:  J Clin Oncol       Date:  2005-12-12       Impact factor: 44.544

Review 2.  Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions.

Authors:  Lawrence J Solin
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

3.  A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk.

Authors:  Troy Bremer; Pat W Whitworth; Rakesh Patel; Jess Savala; Todd Barry; Stephen Lyle; Glen Leesman; Steven P Linke; Karin Jirström; Wenjing Zhou; Rose-Marie Amini; Fredrik Wärnberg
Journal:  Clin Cancer Res       Date:  2018-07-27       Impact factor: 12.531

4.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.

Authors:  B Fisher; S Land; E Mamounas; J Dignam; E R Fisher; N Wolmark
Journal:  Semin Oncol       Date:  2001-08       Impact factor: 4.929

5.  Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.

Authors:  Kimberly J Van Zee; Preeti Subhedar; Cristina Olcese; Sujata Patil; Monica Morrow
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

6.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Authors:  Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

7.  Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Authors:  Constance D Lehman; Constantine Gatsonis; Justin Romanoff; Seema A Khan; Ruth Carlos; Lawrence J Solin; Sunil Badve; Worta McCaskill-Stevens; Ralph L Corsetti; Habib Rahbar; Derrick W Spell; Kenneth B Blankstein; Linda K Han; Jennifer L Sabol; John R Bumberry; Ilana Gareen; Bradley S Snyder; Lynne I Wagner; Kathy D Miller; Joseph A Sparano; Christopher Comstock
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

8.  A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.

Authors:  Eileen Rakovitch; Sharon Nofech-Mozes; Wedad Hanna; Frederick L Baehner; Refik Saskin; Steven M Butler; Alan Tuck; Sandip Sengupta; Leela Elavathil; Prashant A Jani; Michel Bonin; Martin C Chang; Susan J Robertson; Elzbieta Slodkowska; Cindy Fong; Joseph M Anderson; Farid Jamshidian; Dave P Miller; Diana B Cherbavaz; Steven Shak; Lawrence Paszat
Journal:  Breast Cancer Res Treat       Date:  2015-06-29       Impact factor: 4.872

9.  Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.

Authors:  I Sestak; S G Smith; A Howell; J F Forbes; J Cuzick
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

Review 10.  Current approach and future perspective for ductal carcinoma in situ of the breast.

Authors:  Chizuko Kanbayashi; Hiroji Iwata
Journal:  Jpn J Clin Oncol       Date:  2017-08-01       Impact factor: 3.019
View more
  4 in total

Review 1.  Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.

Authors:  Stuart J Schnitt
Journal:  Mod Pathol       Date:  2020-09-09       Impact factor: 7.842

Review 2.  Addressing the problem of overtreatment in breast cancer.

Authors:  Linda M Pak; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2022-05-19       Impact factor: 3.627

3.  "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.

Authors:  Shoshana M Rosenberg; Jennifer M Gierisch; Anna C Revette; Carol L Lowenstein; Elizabeth S Frank; Deborah E Collyar; Thomas Lynch; Alastair M Thompson; Ann H Partridge; E Shelley Hwang
Journal:  Cancer       Date:  2022-02-22       Impact factor: 6.921

Review 4.  Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions.

Authors:  Thaer Khoury
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.